XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS' EQUITY (Tables)
 6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Compensation Cost on Net Earnings
The Company’s results for the three and six months ended June 30, 2023 and 2022 reflected the following stock-based compensation cost, and such compensation cost had the following effects on net earnings:

Increase/(Decrease) for theIncrease/(Decrease) for the
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Cost of sales$545 $277 $959 $676 
Operating expenses3,203 3,535 7,559 6,213 
Net earnings(2,881)(2,933)(6,563)(5,312)
Schedule of Stock Option Activity
Option activity for the six months ended June 30, 2023 and 2022 is summarized below:

For the Six Months Ended June 30, 2023Shares (000s)Weighted
Average
Exercise
Price		Aggregate
Intrinsic
Value		Weighted
Average
Remaining
Contractual
Term
Outstanding as of December 31, 20221,045 $99.82 $27,221 
Granted109 138.09 
Exercised(46)83.43 
Forfeited(11)131.79 
Canceled(1)138.07 
Outstanding as of June 30, 20231,096 $103.96 $35,430 6.2
Exercisable as of June 30, 2023728 $87.95 $34,170 4.8
For the Six Months Ended June 30, 2022Shares (000s)Weighted
Average
Exercise
Price		Aggregate
Intrinsic
Value		Weighted
Average
Remaining
Contractual
Term
Outstanding as of December 31, 2021867 $88.19 $69,711 
Granted109 138.07 
Exercised(18)72.74 
Forfeited(6)120.36 
Canceled— — 
Outstanding as of June 30, 2022952 $93.99 $34,907 6.4
Exercisable as of June 30, 2022666 $81.11 $32,409 5.4
Schedule of Other Information Pertaining to Stock Option Activity
Other information pertaining to option activity during the three and six months ended June 30, 2023 and 2022 is as follows:

 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Weighted-average fair value of options granted$— $— $40.91 $40.26 
Total intrinsic value of stock options exercised ($000s)$597 $495 $2,181 $1,149 
Schedule of Non-vested Restricted Stock Activity
Non-vested restricted stock activity for the six months ended June 30, 2023 and 2022 is summarized below:
Six Months Ended June 30,
20232022
Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 31122 $124.42 166 $99.70 
Granted39 137.48 34 137.74 
Vested(32)110.95 (77)80.84 
Forfeited(4)128.06 (3)116.73 
Non-vested balance as of June 30125 $131.76 120 $122.03 
Schedule of Non-vested Performance Share Activity
Non-vested performance share activity for the six months ended June 30, 2023 and 2022 is summarized below:

Six Months Ended June 30,
20232022
Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 3170 $127.69 69$110.72 
Granted42 139.66 39114.22
Vested(36)98.84 (35)53.17
Forfeited— — (3)84.09
Non-vested balance as of June 3076 $135.25 70$127.69